A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. (Record no. 25008888)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02157 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517040234.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201511s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1530-0293 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1097/CCM.0000000000001132 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Christie, Jason D |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20151104 |
245 00 - TITLE STATEMENT | |
Title | A Randomized Dose-Escalation Study of the Safety and Anti-Inflammatory Activity of the p38 Mitogen-Activated Protein Kinase Inhibitor Dilmapimod in Severe Trauma Subjects at Risk for Acute Respiratory Distress Syndrome. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Critical care medicine |
Date of publication, distribution, etc. | Sep 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1859-69 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | C-Reactive Protein |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Double-Blind Method |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hospital Mortality |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Inflammation Mediators |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interleukin-6 |
General subdivision | biosynthesis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Interleukin-8 |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridones |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidines |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Receptors, Tumor Necrosis Factor, Type I |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Respiratory Distress Syndrome |
General subdivision | prevention & control |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Trauma Severity Indices |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Wounds and Injuries |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | p38 Mitogen-Activated Protein Kinases |
General subdivision | antagonists & inhibitors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Vaslef, Steven |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chang, Philip K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | May, Addison K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Gunn, Scott R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yang, Shuying |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hardes, Kelly |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kahl, Lesley |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Powley, William M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lipson, David A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bayliffe, Andrew I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lazaar, Aili L |
773 0# - HOST ITEM ENTRY | |
Title | Critical care medicine |
Related parts | vol. 43 |
-- | no. 9 |
-- | p. 1859-69 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1097/CCM.0000000000001132">https://doi.org/10.1097/CCM.0000000000001132</a> |
Public note | Available from publisher's website |
No items available.